0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global GnRH Analogues Market Research Report 2024
Published Date: October 2024
|
Report Code: QYRE-Auto-34K18079
Home | Market Reports | Health| Reproductive Health
Global GnRH Analogues Market Research Report 2024
BUY CHAPTERS

Global GnRH Analogues Market Research Report 2024

Code: QYRE-Auto-34K18079
Report
October 2024
Pages:98
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

GnRH Analogues Market

GnRH analogues are synthetic substances that imitate or alter the activity of the natural gonadotropin-releasing hormone (GnRH), used to regulate hormone release for treating conditions like hormone-dependent cancers, gynecological disorders, and fertility issues.
The global GnRH Analogues market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
The development of GnRH analogues has evolved significantly with advancements in pharmaceutical science and technology. Initially, these analogues were designed to either stimulate or inhibit the release of gonadotropins to manage hormone-dependent conditions like cancers and reproductive disorders. Early formulations focused on providing effective short-term treatments. However, recent trends emphasize the creation of long-acting versions that offer sustained hormonal regulation, reducing the need for frequent administration and improving patient adherence. These long-acting formulations include depot injections and implantable devices that release the drug over extended periods, addressing chronic conditions more efficiently.
Another key trend is the advancement in precision medicine, where GnRH analogues are increasingly tailored to specific patient profiles. Modern research is focusing on developing analogues with enhanced selectivity to target particular pathways or receptors with greater accuracy. This personalized approach aims to optimize therapeutic outcomes and minimize side effects. Genetic and hormonal profiling is becoming more integral in determining the most effective treatment regimens, leading to more individualized therapies that cater to the unique needs of each patient.
In parallel, there is growing interest in expanding the applications of GnRH analogues beyond traditional uses. For example, new research is exploring their potential in managing metabolic disorders and autoimmune conditions. Innovations in drug delivery systems, such as novel nanoparticle carriers and smart-release technologies, are also being investigated to enhance the stability and effectiveness of GnRH analogues. As the field progresses, these developments are expected to broaden the therapeutic scope of GnRH analogues, offering improved management options for a variety of hormonal and reproductive health issues.

Report Scope

This report aims to provide a comprehensive presentation of the global market for GnRH Analogues, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GnRH Analogues.
The GnRH Analogues market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global GnRH Analogues market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the GnRH Analogues manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of GnRH Analogues Market Report

Report Metric Details
Report Name GnRH Analogues Market
Segment by Type
  • Agonist
  • Antagonist
Segment by Application
  • Medical Applications
  • Veterinary Applications
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi, Merck, Ferring Pharmaceuticals, AstraZeneca, TerSera Therapeutics, Endo International, Takeda Pharmaceutical, AbbVie, Tolmar, Ipsen Pharma, Praecis Pharmaceuticals, Organon Pharmaceutical, Pfizer, Fuji Pharma, Beijing Biote Pharmaceutical, Luye Pharma, Hybio Pharmaceutical, Livzon Pharmaceutical, Changchun GeneScience Pharmaceuticals, Chongqing Lummy Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of GnRH Analogues manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of GnRH Analogues in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the GnRH Analogues Market report?

Ans: The main players in the GnRH Analogues Market are Sanofi, Merck, Ferring Pharmaceuticals, AstraZeneca, TerSera Therapeutics, Endo International, Takeda Pharmaceutical, AbbVie, Tolmar, Ipsen Pharma, Praecis Pharmaceuticals, Organon Pharmaceutical, Pfizer, Fuji Pharma, Beijing Biote Pharmaceutical, Luye Pharma, Hybio Pharmaceutical, Livzon Pharmaceutical, Changchun GeneScience Pharmaceuticals, Chongqing Lummy Pharmaceutical

What are the Application segmentation covered in the GnRH Analogues Market report?

Ans: The Applications covered in the GnRH Analogues Market report are Medical Applications, Veterinary Applications, Others

What are the Type segmentation covered in the GnRH Analogues Market report?

Ans: The Types covered in the GnRH Analogues Market report are Agonist, Antagonist

1 GnRH Analogues Market Overview
1.1 Product Definition
1.2 GnRH Analogues by Type
1.2.1 Global GnRH Analogues Market Value Comparison by Type (2024-2030)
1.2.2 Agonist
1.2.3 Antagonist
1.3 GnRH Analogues by Application
1.3.1 Global GnRH Analogues Market Value by Application (2024-2030)
1.3.2 Medical Applications
1.3.3 Veterinary Applications
1.3.4 Others
1.4 Global GnRH Analogues Market Size Estimates and Forecasts
1.4.1 Global GnRH Analogues Revenue 2019-2030
1.4.2 Global GnRH Analogues Sales 2019-2030
1.4.3 Global GnRH Analogues Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 GnRH Analogues Market Competition by Manufacturers
2.1 Global GnRH Analogues Sales Market Share by Manufacturers (2019-2024)
2.2 Global GnRH Analogues Revenue Market Share by Manufacturers (2019-2024)
2.3 Global GnRH Analogues Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of GnRH Analogues, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of GnRH Analogues, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of GnRH Analogues, Product Type & Application
2.7 Global Key Manufacturers of GnRH Analogues, Date of Enter into This Industry
2.8 Global GnRH Analogues Market Competitive Situation and Trends
2.8.1 Global GnRH Analogues Market Concentration Rate
2.8.2 The Global 5 and 10 Largest GnRH Analogues Players Market Share by Revenue
2.8.3 Global GnRH Analogues Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global GnRH Analogues Market Scenario by Region
3.1 Global GnRH Analogues Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global GnRH Analogues Sales by Region: 2019-2030
3.2.1 Global GnRH Analogues Sales by Region: 2019-2024
3.2.2 Global GnRH Analogues Sales by Region: 2025-2030
3.3 Global GnRH Analogues Revenue by Region: 2019-2030
3.3.1 Global GnRH Analogues Revenue by Region: 2019-2024
3.3.2 Global GnRH Analogues Revenue by Region: 2025-2030
3.4 North America GnRH Analogues Market Facts & Figures by Country
3.4.1 North America GnRH Analogues Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America GnRH Analogues Sales by Country (2019-2030)
3.4.3 North America GnRH Analogues Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe GnRH Analogues Market Facts & Figures by Country
3.5.1 Europe GnRH Analogues Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe GnRH Analogues Sales by Country (2019-2030)
3.5.3 Europe GnRH Analogues Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific GnRH Analogues Market Facts & Figures by Region
3.6.1 Asia Pacific GnRH Analogues Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific GnRH Analogues Sales by Region (2019-2030)
3.6.3 Asia Pacific GnRH Analogues Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America GnRH Analogues Market Facts & Figures by Country
3.7.1 Latin America GnRH Analogues Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America GnRH Analogues Sales by Country (2019-2030)
3.7.3 Latin America GnRH Analogues Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa GnRH Analogues Market Facts & Figures by Country
3.8.1 Middle East and Africa GnRH Analogues Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa GnRH Analogues Sales by Country (2019-2030)
3.8.3 Middle East and Africa GnRH Analogues Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global GnRH Analogues Sales by Type (2019-2030)
4.1.1 Global GnRH Analogues Sales by Type (2019-2024)
4.1.2 Global GnRH Analogues Sales by Type (2025-2030)
4.1.3 Global GnRH Analogues Sales Market Share by Type (2019-2030)
4.2 Global GnRH Analogues Revenue by Type (2019-2030)
4.2.1 Global GnRH Analogues Revenue by Type (2019-2024)
4.2.2 Global GnRH Analogues Revenue by Type (2025-2030)
4.2.3 Global GnRH Analogues Revenue Market Share by Type (2019-2030)
4.3 Global GnRH Analogues Price by Type (2019-2030)
5 Segment by Application
5.1 Global GnRH Analogues Sales by Application (2019-2030)
5.1.1 Global GnRH Analogues Sales by Application (2019-2024)
5.1.2 Global GnRH Analogues Sales by Application (2025-2030)
5.1.3 Global GnRH Analogues Sales Market Share by Application (2019-2030)
5.2 Global GnRH Analogues Revenue by Application (2019-2030)
5.2.1 Global GnRH Analogues Revenue by Application (2019-2024)
5.2.2 Global GnRH Analogues Revenue by Application (2025-2030)
5.2.3 Global GnRH Analogues Revenue Market Share by Application (2019-2030)
5.3 Global GnRH Analogues Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Company Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi GnRH Analogues Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi GnRH Analogues Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Merck
6.2.1 Merck Company Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck GnRH Analogues Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck GnRH Analogues Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Ferring Pharmaceuticals
6.3.1 Ferring Pharmaceuticals Company Information
6.3.2 Ferring Pharmaceuticals Description and Business Overview
6.3.3 Ferring Pharmaceuticals GnRH Analogues Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Ferring Pharmaceuticals GnRH Analogues Product Portfolio
6.3.5 Ferring Pharmaceuticals Recent Developments/Updates
6.4 AstraZeneca
6.4.1 AstraZeneca Company Information
6.4.2 AstraZeneca Description and Business Overview
6.4.3 AstraZeneca GnRH Analogues Sales, Revenue and Gross Margin (2019-2024)
6.4.4 AstraZeneca GnRH Analogues Product Portfolio
6.4.5 AstraZeneca Recent Developments/Updates
6.5 TerSera Therapeutics
6.5.1 TerSera Therapeutics Company Information
6.5.2 TerSera Therapeutics Description and Business Overview
6.5.3 TerSera Therapeutics GnRH Analogues Sales, Revenue and Gross Margin (2019-2024)
6.5.4 TerSera Therapeutics GnRH Analogues Product Portfolio
6.5.5 TerSera Therapeutics Recent Developments/Updates
6.6 Endo International
6.6.1 Endo International Company Information
6.6.2 Endo International Description and Business Overview
6.6.3 Endo International GnRH Analogues Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Endo International GnRH Analogues Product Portfolio
6.6.5 Endo International Recent Developments/Updates
6.7 Takeda Pharmaceutical
6.7.1 Takeda Pharmaceutical Company Information
6.7.2 Takeda Pharmaceutical Description and Business Overview
6.7.3 Takeda Pharmaceutical GnRH Analogues Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Takeda Pharmaceutical GnRH Analogues Product Portfolio
6.7.5 Takeda Pharmaceutical Recent Developments/Updates
6.8 AbbVie
6.8.1 AbbVie Company Information
6.8.2 AbbVie Description and Business Overview
6.8.3 AbbVie GnRH Analogues Sales, Revenue and Gross Margin (2019-2024)
6.8.4 AbbVie GnRH Analogues Product Portfolio
6.8.5 AbbVie Recent Developments/Updates
6.9 Tolmar
6.9.1 Tolmar Company Information
6.9.2 Tolmar Description and Business Overview
6.9.3 Tolmar GnRH Analogues Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Tolmar GnRH Analogues Product Portfolio
6.9.5 Tolmar Recent Developments/Updates
6.10 Ipsen Pharma
6.10.1 Ipsen Pharma Company Information
6.10.2 Ipsen Pharma Description and Business Overview
6.10.3 Ipsen Pharma GnRH Analogues Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Ipsen Pharma GnRH Analogues Product Portfolio
6.10.5 Ipsen Pharma Recent Developments/Updates
6.11 Praecis Pharmaceuticals
6.11.1 Praecis Pharmaceuticals Company Information
6.11.2 Praecis Pharmaceuticals Description and Business Overview
6.11.3 Praecis Pharmaceuticals GnRH Analogues Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Praecis Pharmaceuticals GnRH Analogues Product Portfolio
6.11.5 Praecis Pharmaceuticals Recent Developments/Updates
6.12 Organon Pharmaceutical
6.12.1 Organon Pharmaceutical Company Information
6.12.2 Organon Pharmaceutical Description and Business Overview
6.12.3 Organon Pharmaceutical GnRH Analogues Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Organon Pharmaceutical GnRH Analogues Product Portfolio
6.12.5 Organon Pharmaceutical Recent Developments/Updates
6.13 Pfizer
6.13.1 Pfizer Company Information
6.13.2 Pfizer Description and Business Overview
6.13.3 Pfizer GnRH Analogues Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Pfizer GnRH Analogues Product Portfolio
6.13.5 Pfizer Recent Developments/Updates
6.14 Fuji Pharma
6.14.1 Fuji Pharma Company Information
6.14.2 Fuji Pharma Description and Business Overview
6.14.3 Fuji Pharma GnRH Analogues Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Fuji Pharma GnRH Analogues Product Portfolio
6.14.5 Fuji Pharma Recent Developments/Updates
6.15 Beijing Biote Pharmaceutical
6.15.1 Beijing Biote Pharmaceutical Company Information
6.15.2 Beijing Biote Pharmaceutical Description and Business Overview
6.15.3 Beijing Biote Pharmaceutical GnRH Analogues Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Beijing Biote Pharmaceutical GnRH Analogues Product Portfolio
6.15.5 Beijing Biote Pharmaceutical Recent Developments/Updates
6.16 Luye Pharma
6.16.1 Luye Pharma Company Information
6.16.2 Luye Pharma Description and Business Overview
6.16.3 Luye Pharma GnRH Analogues Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Luye Pharma GnRH Analogues Product Portfolio
6.16.5 Luye Pharma Recent Developments/Updates
6.17 Hybio Pharmaceutical
6.17.1 Hybio Pharmaceutical Company Information
6.17.2 Hybio Pharmaceutical Description and Business Overview
6.17.3 Hybio Pharmaceutical GnRH Analogues Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Hybio Pharmaceutical GnRH Analogues Product Portfolio
6.17.5 Hybio Pharmaceutical Recent Developments/Updates
6.18 Livzon Pharmaceutical
6.18.1 Livzon Pharmaceutical Company Information
6.18.2 Livzon Pharmaceutical Description and Business Overview
6.18.3 Livzon Pharmaceutical GnRH Analogues Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Livzon Pharmaceutical GnRH Analogues Product Portfolio
6.18.5 Livzon Pharmaceutical Recent Developments/Updates
6.19 Changchun GeneScience Pharmaceuticals
6.19.1 Changchun GeneScience Pharmaceuticals Company Information
6.19.2 Changchun GeneScience Pharmaceuticals Description and Business Overview
6.19.3 Changchun GeneScience Pharmaceuticals GnRH Analogues Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Changchun GeneScience Pharmaceuticals GnRH Analogues Product Portfolio
6.19.5 Changchun GeneScience Pharmaceuticals Recent Developments/Updates
6.20 Chongqing Lummy Pharmaceutical
6.20.1 Chongqing Lummy Pharmaceutical Company Information
6.20.2 Chongqing Lummy Pharmaceutical Description and Business Overview
6.20.3 Chongqing Lummy Pharmaceutical GnRH Analogues Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Chongqing Lummy Pharmaceutical GnRH Analogues Product Portfolio
6.20.5 Chongqing Lummy Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 GnRH Analogues Industry Chain Analysis
7.2 GnRH Analogues Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 GnRH Analogues Production Mode & Process
7.4 GnRH Analogues Sales and Marketing
7.4.1 GnRH Analogues Sales Channels
7.4.2 GnRH Analogues Distributors
7.5 GnRH Analogues Customers
8 GnRH Analogues Market Dynamics
8.1 GnRH Analogues Industry Trends
8.2 GnRH Analogues Market Drivers
8.3 GnRH Analogues Market Challenges
8.4 GnRH Analogues Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global GnRH Analogues Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global GnRH Analogues Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global GnRH Analogues Market Competitive Situation by Manufacturers in 2023
 Table 4. Global GnRH Analogues Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global GnRH Analogues Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global GnRH Analogues Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global GnRH Analogues Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market GnRH Analogues Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of GnRH Analogues, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of GnRH Analogues, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of GnRH Analogues, Product Type & Application
 Table 12. Global Key Manufacturers of GnRH Analogues, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global GnRH Analogues by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GnRH Analogues as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global GnRH Analogues Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global GnRH Analogues Sales by Region (2019-2024) & (K Units)
 Table 18. Global GnRH Analogues Sales Market Share by Region (2019-2024)
 Table 19. Global GnRH Analogues Sales by Region (2025-2030) & (K Units)
 Table 20. Global GnRH Analogues Sales Market Share by Region (2025-2030)
 Table 21. Global GnRH Analogues Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global GnRH Analogues Revenue Market Share by Region (2019-2024)
 Table 23. Global GnRH Analogues Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global GnRH Analogues Revenue Market Share by Region (2025-2030)
 Table 25. North America GnRH Analogues Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America GnRH Analogues Sales by Country (2019-2024) & (K Units)
 Table 27. North America GnRH Analogues Sales by Country (2025-2030) & (K Units)
 Table 28. North America GnRH Analogues Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America GnRH Analogues Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe GnRH Analogues Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe GnRH Analogues Sales by Country (2019-2024) & (K Units)
 Table 32. Europe GnRH Analogues Sales by Country (2025-2030) & (K Units)
 Table 33. Europe GnRH Analogues Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe GnRH Analogues Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific GnRH Analogues Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific GnRH Analogues Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific GnRH Analogues Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific GnRH Analogues Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific GnRH Analogues Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America GnRH Analogues Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America GnRH Analogues Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America GnRH Analogues Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America GnRH Analogues Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America GnRH Analogues Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa GnRH Analogues Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa GnRH Analogues Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa GnRH Analogues Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa GnRH Analogues Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa GnRH Analogues Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global GnRH Analogues Sales (K Units) by Type (2019-2024)
 Table 51. Global GnRH Analogues Sales (K Units) by Type (2025-2030)
 Table 52. Global GnRH Analogues Sales Market Share by Type (2019-2024)
 Table 53. Global GnRH Analogues Sales Market Share by Type (2025-2030)
 Table 54. Global GnRH Analogues Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global GnRH Analogues Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global GnRH Analogues Revenue Market Share by Type (2019-2024)
 Table 57. Global GnRH Analogues Revenue Market Share by Type (2025-2030)
 Table 58. Global GnRH Analogues Price (US$/Unit) by Type (2019-2024)
 Table 59. Global GnRH Analogues Price (US$/Unit) by Type (2025-2030)
 Table 60. Global GnRH Analogues Sales (K Units) by Application (2019-2024)
 Table 61. Global GnRH Analogues Sales (K Units) by Application (2025-2030)
 Table 62. Global GnRH Analogues Sales Market Share by Application (2019-2024)
 Table 63. Global GnRH Analogues Sales Market Share by Application (2025-2030)
 Table 64. Global GnRH Analogues Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global GnRH Analogues Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global GnRH Analogues Revenue Market Share by Application (2019-2024)
 Table 67. Global GnRH Analogues Revenue Market Share by Application (2025-2030)
 Table 68. Global GnRH Analogues Price (US$/Unit) by Application (2019-2024)
 Table 69. Global GnRH Analogues Price (US$/Unit) by Application (2025-2030)
 Table 70. Sanofi Company Information
 Table 71. Sanofi Description and Business Overview
 Table 72. Sanofi GnRH Analogues Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Sanofi GnRH Analogues Product
 Table 74. Sanofi Recent Developments/Updates
 Table 75. Merck Company Information
 Table 76. Merck Description and Business Overview
 Table 77. Merck GnRH Analogues Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Merck GnRH Analogues Product
 Table 79. Merck Recent Developments/Updates
 Table 80. Ferring Pharmaceuticals Company Information
 Table 81. Ferring Pharmaceuticals Description and Business Overview
 Table 82. Ferring Pharmaceuticals GnRH Analogues Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Ferring Pharmaceuticals GnRH Analogues Product
 Table 84. Ferring Pharmaceuticals Recent Developments/Updates
 Table 85. AstraZeneca Company Information
 Table 86. AstraZeneca Description and Business Overview
 Table 87. AstraZeneca GnRH Analogues Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. AstraZeneca GnRH Analogues Product
 Table 89. AstraZeneca Recent Developments/Updates
 Table 90. TerSera Therapeutics Company Information
 Table 91. TerSera Therapeutics Description and Business Overview
 Table 92. TerSera Therapeutics GnRH Analogues Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. TerSera Therapeutics GnRH Analogues Product
 Table 94. TerSera Therapeutics Recent Developments/Updates
 Table 95. Endo International Company Information
 Table 96. Endo International Description and Business Overview
 Table 97. Endo International GnRH Analogues Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Endo International GnRH Analogues Product
 Table 99. Endo International Recent Developments/Updates
 Table 100. Takeda Pharmaceutical Company Information
 Table 101. Takeda Pharmaceutical Description and Business Overview
 Table 102. Takeda Pharmaceutical GnRH Analogues Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Takeda Pharmaceutical GnRH Analogues Product
 Table 104. Takeda Pharmaceutical Recent Developments/Updates
 Table 105. AbbVie Company Information
 Table 106. AbbVie Description and Business Overview
 Table 107. AbbVie GnRH Analogues Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. AbbVie GnRH Analogues Product
 Table 109. AbbVie Recent Developments/Updates
 Table 110. Tolmar Company Information
 Table 111. Tolmar Description and Business Overview
 Table 112. Tolmar GnRH Analogues Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Tolmar GnRH Analogues Product
 Table 114. Tolmar Recent Developments/Updates
 Table 115. Ipsen Pharma Company Information
 Table 116. Ipsen Pharma Description and Business Overview
 Table 117. Ipsen Pharma GnRH Analogues Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. Ipsen Pharma GnRH Analogues Product
 Table 119. Ipsen Pharma Recent Developments/Updates
 Table 120. Praecis Pharmaceuticals Company Information
 Table 121. Praecis Pharmaceuticals Description and Business Overview
 Table 122. Praecis Pharmaceuticals GnRH Analogues Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. Praecis Pharmaceuticals GnRH Analogues Product
 Table 124. Praecis Pharmaceuticals Recent Developments/Updates
 Table 125. Organon Pharmaceutical Company Information
 Table 126. Organon Pharmaceutical Description and Business Overview
 Table 127. Organon Pharmaceutical GnRH Analogues Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 128. Organon Pharmaceutical GnRH Analogues Product
 Table 129. Organon Pharmaceutical Recent Developments/Updates
 Table 130. Pfizer Company Information
 Table 131. Pfizer Description and Business Overview
 Table 132. Pfizer GnRH Analogues Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 133. Pfizer GnRH Analogues Product
 Table 134. Pfizer Recent Developments/Updates
 Table 135. Fuji Pharma Company Information
 Table 136. Fuji Pharma Description and Business Overview
 Table 137. Fuji Pharma GnRH Analogues Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 138. Fuji Pharma GnRH Analogues Product
 Table 139. Fuji Pharma Recent Developments/Updates
 Table 140. Beijing Biote Pharmaceutical Company Information
 Table 141. Beijing Biote Pharmaceutical Description and Business Overview
 Table 142. Beijing Biote Pharmaceutical GnRH Analogues Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 143. Beijing Biote Pharmaceutical GnRH Analogues Product
 Table 144. Beijing Biote Pharmaceutical Recent Developments/Updates
 Table 145. Luye Pharma Company Information
 Table 146. Luye Pharma Description and Business Overview
 Table 147. Luye Pharma GnRH Analogues Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 148. Luye Pharma GnRH Analogues Product
 Table 149. Luye Pharma Recent Developments/Updates
 Table 150. Hybio Pharmaceutical Company Information
 Table 151. Hybio Pharmaceutical Description and Business Overview
 Table 152. Hybio Pharmaceutical GnRH Analogues Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 153. Hybio Pharmaceutical GnRH Analogues Product
 Table 154. Hybio Pharmaceutical Recent Developments/Updates
 Table 155. Livzon Pharmaceutical Company Information
 Table 156. Livzon Pharmaceutical Description and Business Overview
 Table 157. Livzon Pharmaceutical GnRH Analogues Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 158. Livzon Pharmaceutical GnRH Analogues Product
 Table 159. Livzon Pharmaceutical Recent Developments/Updates
 Table 160. Changchun GeneScience Pharmaceuticals Company Information
 Table 161. Changchun GeneScience Pharmaceuticals Description and Business Overview
 Table 162. Changchun GeneScience Pharmaceuticals GnRH Analogues Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 163. Changchun GeneScience Pharmaceuticals GnRH Analogues Product
 Table 164. Changchun GeneScience Pharmaceuticals Recent Developments/Updates
 Table 165. Chongqing Lummy Pharmaceutical Company Information
 Table 166. Chongqing Lummy Pharmaceutical Description and Business Overview
 Table 167. Chongqing Lummy Pharmaceutical GnRH Analogues Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 168. Chongqing Lummy Pharmaceutical GnRH Analogues Product
 Table 169. Chongqing Lummy Pharmaceutical Recent Developments/Updates
 Table 170. Key Raw Materials Lists
 Table 171. Raw Materials Key Suppliers Lists
 Table 172. GnRH Analogues Distributors List
 Table 173. GnRH Analogues Customers List
 Table 174. GnRH Analogues Market Trends
 Table 175. GnRH Analogues Market Drivers
 Table 176. GnRH Analogues Market Challenges
 Table 177. GnRH Analogues Market Restraints
 Table 178. Research Programs/Design for This Report
 Table 179. Key Data Information from Secondary Sources
 Table 180. Key Data Information from Primary Sources
 Table 181. Authors List of This Report


List of Figures
 Figure 1. Product Picture of GnRH Analogues
 Figure 2. Global GnRH Analogues Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global GnRH Analogues Market Share by Type: 2023 & 2030
 Figure 4. Agonist Product Picture
 Figure 5. Antagonist Product Picture
 Figure 6. Global GnRH Analogues Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global GnRH Analogues Market Share by Application: 2023 & 2030
 Figure 8. Medical Applications
 Figure 9. Veterinary Applications
 Figure 10. Others
 Figure 11. Global GnRH Analogues Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 12. Global GnRH Analogues Market Size (2019-2030) & (US$ Million)
 Figure 13. Global GnRH Analogues Sales (2019-2030) & (K Units)
 Figure 14. Global GnRH Analogues Average Price (US$/Unit) & (2019-2030)
 Figure 15. GnRH Analogues Report Years Considered
 Figure 16. GnRH Analogues Sales Share by Manufacturers in 2023
 Figure 17. Global GnRH Analogues Revenue Share by Manufacturers in 2023
 Figure 18. Global 5 and 10 Largest GnRH Analogues Players: Market Share by Revenue in GnRH Analogues in 2023
 Figure 19. GnRH Analogues Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 20. Global GnRH Analogues Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 21. North America GnRH Analogues Sales Market Share by Country (2019-2030)
 Figure 22. North America GnRH Analogues Revenue Market Share by Country (2019-2030)
 Figure 23. United States GnRH Analogues Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Canada GnRH Analogues Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Europe GnRH Analogues Sales Market Share by Country (2019-2030)
 Figure 26. Europe GnRH Analogues Revenue Market Share by Country (2019-2030)
 Figure 27. Germany GnRH Analogues Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. France GnRH Analogues Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. U.K. GnRH Analogues Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Italy GnRH Analogues Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Russia GnRH Analogues Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Asia Pacific GnRH Analogues Sales Market Share by Region (2019-2030)
 Figure 33. Asia Pacific GnRH Analogues Revenue Market Share by Region (2019-2030)
 Figure 34. China GnRH Analogues Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Japan GnRH Analogues Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. South Korea GnRH Analogues Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. India GnRH Analogues Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Australia GnRH Analogues Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. China Taiwan GnRH Analogues Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Southeast Asia GnRH Analogues Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Latin America GnRH Analogues Sales Market Share by Country (2019-2030)
 Figure 42. Mexico GnRH Analogues Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Brazil GnRH Analogues Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Argentina GnRH Analogues Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Colombia GnRH Analogues Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Middle East and Africa GnRH Analogues Sales Market Share by Country (2019-2030)
 Figure 47. Middle East and Africa GnRH Analogues Revenue Market Share by Country (2019-2030)
 Figure 48. Turkey GnRH Analogues Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Saudi Arabia GnRH Analogues Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. UAE GnRH Analogues Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Global Sales Market Share of GnRH Analogues by Type (2019-2030)
 Figure 52. Global Revenue Market Share of GnRH Analogues by Type (2019-2030)
 Figure 53. Global GnRH Analogues Price (US$/Unit) by Type (2019-2030)
 Figure 54. Global Sales Market Share of GnRH Analogues by Application (2019-2030)
 Figure 55. Global Revenue Market Share of GnRH Analogues by Application (2019-2030)
 Figure 56. Global GnRH Analogues Price (US$/Unit) by Application (2019-2030)
 Figure 57. GnRH Analogues Value Chain
 Figure 58. GnRH Analogues Production Process
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Add to Cart

Drugs for Vaginal Fungal Infections - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-27A13667
Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Preeclampsia Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-39U13956
Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Pregnancy & Breastfeeding Bras - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-31G13595
Mon Oct 21 00:00:00 UTC 2024

Add to Cart